Susan G Komen  
I've Been Diagnosed With Breast Cancer Someone I Know Was Diagnosed Share Your Story Join Us And Stay Informed Donate To End Breast Cancer
    Home > Research & Grants > Grants Program > Research Grants > Research Grants Awarded

    Research Grants Awarded

    2004-2005 Grant Cycle : Research Grants Awarded

    Biology of Breast Cancer

    Characterization of VSV Oncolytic Activity in Breast Cancer Model Systems
    Glen Barber, PhD
    Paula Faria
    University of Miami

    $135,000


    Radiation and TGF Beta as Mediators of Stromal Activation in Breast Carcinogenesis
    Mary Helen Barcellos-Hoff, PhD
    Jenny Paupert
    Lawrence Berkeley National Labs

    $135,000


    Role of Small GTPase RhoB in Breast Tumorigenesis
    Laura Benjamin, PhD
    Shiva Kazerounian
    Beth Israel Deaconess Medical Center/Harvard Medical School

    $135,000


    The Type III TGF-Beta Receptor as a Candidate Tumor Suppressor Gene in Breast Cancer
    Gerard Blobe, MD,PhD
    Mei Dong
    Duke University

    $135,000


    Crosstalk Between Extrinsic and Intrinsic Caspase Activation Pathways in Doxorubicin-Mediated Sensitization of Breast Cancer Cells to TRAIL-Induced Apoptosis
    Matthew Bogyo, PhD
    Kelly Boatright
    Stanford University School of Medicine

    $135,000


    LDP1 Directly Links the Tumor Suppressor Protein P53 to Iron Metabolism
    Rainer Brachmann, MD
    Lawrence Dearth
    University of California, Irvine

    $133,864


    The Differential Effects of Estrogen on Gene Regulation and Apoptosis in the Breast and Bone
    Myles Brown, MD
    Susan Krum
    Dana-Farber Cancer Institute

    $135,000


    Scaffolding Proteins and Rho Signaling in Breast Cancer
    Keith Burridge, PhD
    Rafael Garcia-Mata
    University of North Carolina at Chapel Hill

    $135,000


    IRF-1-Dependent Apoptosis and Antiestrogen Sensitivity in Breast Cancer
    Robert Clarke, PhD, Dphil
    Rebecca Riggins
    Georgetown University, Lombardi Comprehensive Cancer Center

    $90,000


    Identification, Expression Profiling and Functional Analysis of MicroRNAs in Breast Cancer
    Charles Cole, PhD
    Lorenzo Sempere
    Dartmouth Medical School

    $134,500


    Identification of Substrates of the Her2/neu Tyrosine Kinase in Breast Cancer Cell Lines using Chemical Rescue of a Her2/neu Catalytic Loop Point Mutation
    Philip Cole, MD PhD
    Ron Bose
    Johns Hopkins University

    $90,000


    Profiling Enzyme Activities in Human Breast Cancer
    Benjamin Cravatt, PhD
    BinQing Wei
    The Scripps Research Institute

    $134,925


    Investigation of the Role Played by BRCA1 in the Activation of FANCD2 Following Chemotherapy Induced DNA Damage
    Alan D'Andrea, MD
    Richard Kennedy
    Dana-Farber Cancer Institute

    $135,000


    Regulation of the Cellular Senescence Program by RB Proteins
    Brian Dynlacht, PhD
    Nathan Lents
    New York University School of Medicine

    $135,000


    Notch Regulation of Epithelial-Mesenchymal Transition During Wound Healing and Migration of Mammary Epithelial Cells
    Alan Hall, B.A., PHD.
    Karni Schlessinger
    University College London, MRC-LMCB

    $135,000


    An Investigation of p21CIP1 Function During Breast Cancer Metastasis
    Rachel Hazan, PhD
    James Hulit
    Albert Einstein College of Medicine of Yeshiva University

    $135,000


    DNA Vaccines Against Breast Cancer: Synergy Through Targeting Both Tumor Cells and Tumor Stroma
    Alan Houghton, MD
    Francesca Orlandi
    Sloan-Kettering Institute for Cancer Research

    $135,000


    Roles of Chk1 Kinase in Breast Cancer Etiology and Therapy
    Tony Hunter, PhD
    You-Wei Zhang
    The Salk Institute for Biological Studies

    $135,000


    Novel Signaling Mechanisms of CXCR4-induced Chemotaxis
    Richard Klemke, PhD
    Yingchun Wang
    The Regents of the University of California, University of California, San Diego

    $135,000


    The Role of E2F3 in Breast Cancer
    Gustavo Leone, PhD
    Shu-Huei Wang
    The Ohio State University Research Foundation

    $135,000


    Synergism Between c-Src and EGFR Intracellular Trafficking in Breast Cancer
    Marilyn Resh, AB, PhD
    Mrudula Donepudi
    Memorial Sloan-Kettering Cancer Center

    $135,000


    Structure and Biochemistry of the Homologous DNA Recombinase Rad51
    Phoebe Rice, PhD
    Arabela Grigorescu
    University of Chicago

    $135,000


    Small animal ultrasound to examine the role of AIB1 and its isoform in estrogen receptor alpha-initiated preneoplasia and DCIS
    Anna Riegel, MS PhD
    Maddalena Tilli
    Lombardi Cancer Center

    $135,000


    The Role of TRAP220 in Estrogen Receptor-Dependent Function and in Mammary Gland Development and Neoplasia
    Robert Roeder, PhD
    Xiaotiing Zhang
    The Rockefeller University

    $135,000


    Identification and Characterization of Breast Cancer Stem Cells
    Jeffrey Rosen, PhD
    Mei Zhang
    Baylor College of Medicine

    $135,000


    Tamoxifen Response Pathway Characterization by Reversible Gene Entrapment of Breast Cancer Cells
    H. Earl Ruley, PhD
    Sarah Donahue
    Vanderbilt University Medical Center

    $135,000


    Genetic Understanding of Locally Advanced Breast Cancer
    Robert Schneider, PhD
    Ksenia Karpisheva
    New York University School of Medicine

    $135,000


    The Role of Shp2 in the Alpha 6 Beta 4 Integrin-dependent Metastasis
    Leslie Shaw, PhD
    Udayan Dutta
    University of Massachusetts Medical School

    $90,000


    Structural and Biochemical Characterization of PGC-1a Coactivation of the Tumor Suppressor Protein P53
    Bruce Spiegelman, PhD
    srikripa devarakonda
    Dana-Farber Cancer Institute

    $135,000


    Delineation of the role of the tumor suppressor BRCA2 in homologous recombination and DNA repair
    Patrick Sung, Dphil
    Joseph San Filippo
    Yale University

    $135,000


    Chromatin and the Regulation of DNA Double-Strand Breaks
    Anne Villeneuve, PhD
    Jessica Bessler
    Stanford University

    $135,000


    Disregulation of Stem Cell Self-renewal in Breast Cancer Development
    Max Wicha, MD
    Suling Liu
    University of Michigan

    $135,000


    Use of Molecular Imaging and Genetic Approaches to Investigate the Role of Tumor Lymphangiogenesis in Breast Cancer Metastasis
    Lily Wu, PhD, MD
    Yufang Hu
    University of California, Los Angeles

    $90,000


    Early Detections, Diagnosis, and Prognosis

    Development of Marlers that Predict Resistance to Omnitarg in Breast Cancer
    Joe Gray, PhD
    Yinghui Guan
    Ed Lawrence Berkeley National Laboratory

    $135,000


    Etiology

    Estrogen Receptor AF-1 Interacting Proteins and Peptides
    Geoffrey Greene, PhD
    Hoyee Leong
    University of Chicago

    $135,000


    Orphan Nuclear Receptor PXR in Estrogen Deprivation and Breast Cancer
    Wen Xie, PhD, MD
    Haibiao Gong
    University of Pittsburgh

    $135,000


    Prevention

    Targeting a Novel Breast Differentiation Antigen for Breast Cancer Immunotherapy
    Stanley Riddell, MD
    Wei Wang
    Fred Hutchinson Cancer Research Center

    $135,000


    Scientific Model Systems

    Improved Xenotransplant Model for Human Breast Cancer
    Hallgeir Rui, PhD, MD
    Fransiscus Utama
    Georgetown University

    $135,000


    Treatment

    Antitumoral Efficacy of Novel Inhibitors of the Fatty Acid Synthase
    Ramon Colomer, medical doctor (oncologist) and PhD.
    RUT PORTA
    Intitut Catala d'Oncologia - Hospital Universitari Dr.Josep Trueta

    $135,000


    E2F-1 and Telomeres: A Combined Strategy for Treatment and Prognosis of Breast Cancer
    Kelly Hunt, MD
    Michelle Fanale
    University of Texas M.D. Anderson Cancer Center

    $135,000


    Targeting Retrovirus Replication for Gene Therapy of Breast Cancer
    Noriyuki Kasahara, MD, PhD
    Kei Hiraoka
    University of California, Los Angeles

    $135,000


    Total Synthesis of Apoptolidin and Analogs
    Gary Molander, PhD
    Frieman Bryan
    University of Pennsylvania

    $125,238



    * Pending executed agreement